Company profile: Hammersmith Medicines Research
1.1 - Company Overview
Company description
- Provider of contract research services for phase 1 and early phase 2 clinical trials, including volunteer recruitment, trial design, data management and statistical analysis. Offers laboratory services (biomarker assays, DNA extraction/PCR, flow cytometry, ELISA), pharmacy manufacturing (sterile/non-sterile, radiopharmaceuticals), QA and regulatory compliance (GMP, ISO 27001), and accredited COVID-19 testing.
Products and services
- Clinical Trials Services: HMR architects early-phase-focused trials, delivering volunteer recruitment, trial design, data management and analysis, supported by 100 beds, 5800 m² premises, and a polysomnography sleep unit
- Pharmacy Services: HMR produces investigational medicinal products via GMP-adherent sterile and non-sterile manufacturing, including solutions, capsules, radiopharmaceuticals, with secure storage, dispensing, aseptic unit access, and radiopharmacy capability
- Laboratory Services: HMR offers flow cytometry-capable biological sample analysis, performing DNA extraction and PCR and running automated ELISA analysers for safety testing and pharmacodynamic biomarker assays
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Hammersmith Medicines Research
Meridien Research
HQ: United States
Website
- Description: Provider of opportunities for patients and families to participate in clinical research trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Meridien Research company profile →
Northeast Biolab
HQ: United States
Website
- Description: Provider of GLP and clinical bioanalysis services with 15+ years of experience, offering method development, validation and transfer; LC-MS bioanalysis; pharmacokinetics sample analysis and toxicokinetic safety testing; and assay platforms including ELISA, MSD, qPCR/ddPCR, Western Blot and In Cell Western for drug testing and biomarker analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Northeast Biolab company profile →
Pharm-Olam
HQ: United States
Website
- Description: Provider of comprehensive clinical research services as a multi-national contract research organization serving pharmaceutical, biotechnology, and medical device industries, with a global network including Central Eastern Europe, Latin America, and India to enable patient recruitment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharm-Olam company profile →
Natural Pharmaceuticals
HQ: Poland
Website
- Description: Provider of science- and technology-driven health offerings focused on the Omega-3 segment; a Norwegian market leader dedicated to raising awareness among Central European consumers of the health benefits of diets rich in fish and marine fatty acids.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Natural Pharmaceuticals company profile →
Premier Research
HQ: United Kingdom
Website
- Description: Provider of clinical trial and regulatory services for biopharmaceutical and medical device companies, including clinical operations (site selection, patient enrollment), project management and delivery, data management and biostatistics, medical and regulatory affairs (EU MDR compliance, clinical evaluation), functional services (biometrics, regulatory support), and records management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Premier Research company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Hammersmith Medicines Research
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Hammersmith Medicines Research
2.2 - Growth funds investing in similar companies to Hammersmith Medicines Research
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Hammersmith Medicines Research
4.2 - Public trading comparable groups for Hammersmith Medicines Research
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →